201 related articles for article (PubMed ID: 20173099)
1. Sampling the N-terminal proteome of human blood.
Wildes D; Wells JA
Proc Natl Acad Sci U S A; 2010 Mar; 107(10):4561-6. PubMed ID: 20173099
[TBL] [Abstract][Full Text] [Related]
2. Colon tumour secretopeptidome: insights into endogenous proteolytic cleavage events in the colon tumour microenvironment.
Greening DW; Kapp EA; Ji H; Speed TP; Simpson RJ
Biochim Biophys Acta; 2013 Nov; 1834(11):2396-407. PubMed ID: 23684732
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis.
Nissum M; Kuhfuss S; Hauptmann M; Obermaier C; Sukop U; Wildgruber R; Weber G; Eckerskorn C; Malmström J
Proteomics; 2007 Dec; 7(23):4218-27. PubMed ID: 17973290
[TBL] [Abstract][Full Text] [Related]
4. Unbiased selective isolation of protein N-terminal peptides from complex proteome samples using phospho tagging (PTAG) and TiO(2)-based depletion.
Mommen GP; van de Waterbeemd B; Meiring HD; Kersten G; Heck AJ; de Jong AP
Mol Cell Proteomics; 2012 Sep; 11(9):832-42. PubMed ID: 22729381
[TBL] [Abstract][Full Text] [Related]
5. Positional proteomics in the era of the human proteome project on the doorstep of precision medicine.
Eckhard U; Marino G; Butler GS; Overall CM
Biochimie; 2016 Mar; 122():110-8. PubMed ID: 26542287
[TBL] [Abstract][Full Text] [Related]
6. Sample preparation by in-gel digestion for mass spectrometry-based proteomics.
Granvogl B; Plöscher M; Eichacker LA
Anal Bioanal Chem; 2007 Oct; 389(4):991-1002. PubMed ID: 17639354
[TBL] [Abstract][Full Text] [Related]
7. The DegraBase: a database of proteolysis in healthy and apoptotic human cells.
Crawford ED; Seaman JE; Agard N; Hsu GW; Julien O; Mahrus S; Nguyen H; Shimbo K; Yoshihara HA; Zhuang M; Chalkley RJ; Wells JA
Mol Cell Proteomics; 2013 Mar; 12(3):813-24. PubMed ID: 23264352
[TBL] [Abstract][Full Text] [Related]
8. Plasma proteome response to severe burn injury revealed by 18O-labeled "universal" reference-based quantitative proteomics.
Qian WJ; Petritis BO; Kaushal A; Finnerty CC; Jeschke MG; Monroe ME; Moore RJ; Schepmoes AA; Xiao W; Moldawer LL; Davis RW; Tompkins RG; Herndon DN; Camp DG; Smith RD;
J Proteome Res; 2010 Sep; 9(9):4779-89. PubMed ID: 20698492
[TBL] [Abstract][Full Text] [Related]
9. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
[TBL] [Abstract][Full Text] [Related]
10. Identification of proteolytic products and natural protein N-termini by Terminal Amine Isotopic Labeling of Substrates (TAILS).
Doucet A; Kleifeld O; Kizhakkedathu JN; Overall CM
Methods Mol Biol; 2011; 753():273-87. PubMed ID: 21604129
[TBL] [Abstract][Full Text] [Related]
11. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
Percy AJ; Chambers AG; Yang J; Borchers CH
Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
[TBL] [Abstract][Full Text] [Related]
13. Affinity depletion of plasma and serum for mass spectrometry-based proteome analysis.
Jaros JA; Guest PC; Bahn S; Martins-de-Souza D
Methods Mol Biol; 2013; 1002():1-11. PubMed ID: 23625390
[TBL] [Abstract][Full Text] [Related]
14. Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome.
Lange PF; Huesgen PF; Nguyen K; Overall CM
J Proteome Res; 2014 Apr; 13(4):2028-44. PubMed ID: 24555563
[TBL] [Abstract][Full Text] [Related]
15. Amino-Terminal Oriented Mass Spectrometry of Substrates (ATOMS) N-terminal sequencing of proteins and proteolytic cleavage sites by quantitative mass spectrometry.
Doucet A; Overall CM
Methods Enzymol; 2011; 501():275-93. PubMed ID: 22078539
[TBL] [Abstract][Full Text] [Related]
16. ProC-TEL: Profiling of Protein C-Termini by Enzymatic Labeling.
Duan W; Xu G
Methods Mol Biol; 2017; 1574():135-144. PubMed ID: 28315248
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic Standards.
Kramer G; Woolerton Y; van Straalen JP; Vissers JP; Dekker N; Langridge JI; Beynon RJ; Speijer D; Sturk A; Aerts JM
PLoS One; 2015; 10(10):e0140097. PubMed ID: 26474480
[TBL] [Abstract][Full Text] [Related]
18. Isoform analysis of LC-MS/MS data from multidimensional fractionation of the serum proteome.
Krasnoselsky AL; Faca VM; Pitteri SJ; Zhang Q; Hanash SM
J Proteome Res; 2008 Jun; 7(6):2546-52. PubMed ID: 18419151
[TBL] [Abstract][Full Text] [Related]
19. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
Turtoi A; Mazzucchelli GD; De Pauw E
Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer.
Zheng X; Baker H; Hancock WS
J Chromatogr A; 2006 Jul; 1120(1-2):173-84. PubMed ID: 16527286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
